Heparin-derived oligosaccharide-C3

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHeparin-derived oligosaccharide-C3
Drug Alias NameNeuroparinSubeparinOligotropinHF-0420HDO-C3
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLoyola University Chicago
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLoyola University ChicagoNewron Pharmaceutical
Active IndicationsN/A
Inactive IndicationsPeripheral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A